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DNA microarray technologies are used in a vari-
ety of biological disciplines. The diversity of plat-
forms and analytical methods employed has
raised concerns over the reliability, reproducibility
and correlation of data produced across the dif-
ferent approaches. Initial investigations (years
2000–2003) found discrepancies in the gene
expression measures produced by different micro-
array technologies. Increasing knowledge and
control of the factors that result in poor correlation
among the technologies has led to much higher
levels of correlation among more recent publica-
tions (years 2004 to present). Here, we review
the studies examining the correlation among
microarray technologies. We ﬁnd that with im-
provements in the technology (optimization and
standardization of methods, including data analy-
sis) and annotation, analysis across platforms
yields highly correlated and reproducible results.
We suggest several key factors that should be
controlled in comparing across technologies, and
are good microarray practice in general. Envi-
ron. Mol. Mutagen. 48:380–394, 2007.
V V C 2007 Wiley-Liss, Inc.
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INTRODUCTION
DNA microarrays are quickly becoming standard tools
in molecular biology, providing a powerful approach for
the analysis of global transcriptional response. Over the
past decade, microarrays have been widely used across
biological disciplines and the number of published studies
using the technology is still increasing (Fig. 1). As a
result, the number of commercial suppliers of microar-
rays, associated reagents, hardware, and software contin-
ues to grow [Kawasaki, 2006; Technology Feature, 2006].
The diversity of microarray technologies and methods
of data analysis have resulted in growing concern over
the relationship among data obtained and published using
different approaches. A number of impressive efforts have
recently been made to develop standards for microarray
experiments including the Minimum Information About a
Microarray Experiment (MIAME) guidelines [Brazma
et al., 2001; http://www.mged.org/Workgroups/MIAME/
miame.html], the External RNA Controls Consortium
(ERCC) [Baker et al., 2005; http://www.cstl.nist.gov/
biotech/Cell&TissueMeasurements/GeneExpression/ERCC.
htm], and the Microarray Quality Control project (MAQC)
[http://www.fda.gov/nctr/science/centers/toxicoinformatics/
maqc/; Shi et al., 2006]. These projects have made signiﬁ-
cant advances toward improving the evaluation of micro-
array data quality and the reproducibility of results among
laboratories and platforms. A large majority of journals
have made submission of microarray data to publicly-
available repositories and adherence to the MIAME stand-
ards compulsory for publication of experiments utilizing DNA
microarrays. Adherence to established standards, along-
side proven reproducibility and correlation within and
between datasets produced by different microarray plat-
forms, is essential for the usefulness of such databases.
Furthermore, establishing the correlation and reproducibil-
ity among different microarray technologies is important
for the validation of microarrays as robust, sensitive, and
accurate detectors of differential gene expression.
Over 40 studies have been carried out since 2000 to
evaluate the extent to which data produced by different
microarray technologies correlate. In this review, we sum-
marize the cross-platform studies designed to examine the
correlation of gene expression proﬁles and differentially
expressed genes among different DNA microarray tech-
nologies. The potential reasons for discrepancies reported
in earlier comparative studies, and the methodological
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reported in more recent publications are discussed.
ABRIEFOVERVIEWOF TECHNOLOGICAL AND
ANALYTICALCHOICES
Various technical and analytical options are available
for microarray experiments (Fig. 2). These options are
sometimes governed by the selection of microarray plat-
form. For example, a decision to use Affymetrix chips
[http://www.affymetrix.com/; McGall et al., 1996] limits
the choice of scanner, and subsequent steps through to
image analysis, to those supplied by Affymetrix. The
Affymetrix technology uses a combination of oligonucleo-
tide synthesis and photolithography to position speciﬁc
oligonucleotide probes in a predetermined spatial orienta-
tion. Each gene is represented by a series of different oli-
gonucleotide probes spanning the coding region of that
gene [Liu et al., 2003]. Each oligonucleotide probe is
paired with a mismatch probe in which the central base in
the sequence has been changed. Therefore, application of
the Affymetrix system is heavily directed by the manufac-
turer’s recommendations. However, for experiments using
microarrays that are spotted on glass microscope slides, a
number of alternatives are available that may contribute
to variation in the data acquired (Fig. 2).
Several comprehensive reviews cover different microar-
ray platforms and approaches [Sevenet and Cussenot,
2003; Hardiman, 2004; Stoughton, 2005; Ahmed, 2006a,b;
Kawasaki, 2006]; readers are directed to these sources for
a more in-depth overview of microarray technologies.
Below, some typical options that can contribute to techni-
cal variation in the gene expression measurements acquired
between different technologies are brieﬂy summarized
(Fig. 2).
Probe choices for microarrays may include ampliﬁed
cDNA clones, PCR gene products, or different lengths of
oligonucleotides [Kawasaki, 2006]. Studies examining the
correlation among microarray technologies have focused
primarily on differences between probe types. However,
many other factors contribute to technical variability.
Methods of printing/deposition of probes onto glass slides
include contact-spotting using pins, deposition by ink jet,
or in situ synthesis of oligonucleotides on the slide
[Hughes et al., 2001; Gao et al., 2004]. Slide surfaces
may be coated with different types of matrices that gov-
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Fig. 1. Number of publications retrieved from PubMed* using DNA
microarray technologies. *PubMed search criteria: ‘‘microarray’’ [all
ﬁelds] OR ‘‘microarrays’’ [all ﬁelds] OR ‘‘genechip’’ [all ﬁelds] OR
‘‘genechips’’ [all ﬁelds] AND ‘‘dna’’ [all ﬁelds] OR ‘‘cdna’’ [all ﬁelds]
OR ‘‘complimentary dna’’ [all ﬁelds] OR ‘‘oligonucleotides’’ [all ﬁelds]
OR ‘‘oligonucleotide’’ [all ﬁelds] Limits: XXXX [Publication Date].
Fig. 2. Summary of choices for microarray experiments.
CorrelationAmongDNA Microarray Technologies 381ern the afﬁnity of probe binding and affect background
ﬂuorescence [Rickman et al., 2003; Sobek et al., 2006].
Target preparation varies and may include different
amounts of starting RNA, ampliﬁcation, and labeling
methods [Gold et al., 2004; Hardiman, 2004; Schindler
et al., 2005; Singh et al., 2005; Kawasaki, 2006], all of
which contribute to the type and quality of data produced.
In addition, cDNA and several oligonucleotide platforms
allow experiments to be carried out in one or two colors
[Patterson et al., 2006]. Two color experiments may
involve dye-swap, reference RNA, or loop designs [Vin-
ciotti et al., 2005; Patterson et al., 2006]. Hybridization
can be undertaken manually or using automated hybrid-
ization stations; optimization of methods is important to
minimize array variability and hybridization artifacts
[Yauk et al., 2005; Han et al., 2006; Yauk et al., 2006].
The scanner (high or low laser powers) and scanner set-
tings inﬂuence background ﬂuorescence, the number of
saturated spots and the number of spots below back-
ground [Shi et al., 2005b; Timlin, 2006], and should be
adjusted to maximize the linear dynamic range. Acquisi-
tion of data from images can be carried out using various
algorithms through different commercial packages. The
ﬁnal critical steps include applying the appropriate ﬁlter-
ing methods, evaluating microarray data quality [Shi
et al., 2004], normalization [Bilban et al., 2002b; Quack-
enbush, 2002], and data analysis [Shi et al., 2005a; Jeff-
ery et al., 2006]. Normalization and detection of differen-
tial gene expression are key to ensuring the accuracy and
reproducibility of data across time, laboratories, and plat-
forms, and are reviewed in detail elsewhere [Bilban et al.,
2002b; Quackenbush, 2002; Armstrong and van de Wiel,
2004; Reimers, 2005; Breitling, 2006]
CORRELATIONAMONGTECHNOLOGIES
Data obtained from different commercially-made and
in-house microarray platforms have been compared in a
large number of studies. Experiments have been carried
out to determine the effective differences in accuracy
(proximity to true value), sensitivity (ability to accurately
detect changes at low concentrations), and speciﬁcity (to
hybridize to the correct gene) among the technologies
[Hardiman, 2004; van Bakel and Holstege, 2004; Draghici
et al., 2006]. Intra-platform variability and reproducibility
have been used as measures of the quality of the data pro-
duced for individual platforms. Several of these studies
have been aimed at answering the question ‘‘which plat-
form is the best?’’ The answer to this question is inargu-
ably experiment-speciﬁc. A more relevant question is
‘which platforms generate comparable and reproducible
data?’
In the remaining sections, experiments investigating the
reproducibility of data among DNA microarray technolo-
gies and the correlation among these data with respect to
expression proﬁles and the identiﬁcation of differentially
expressed genes are reviewed.
EARLYSTUDIES: 2000^2003
For the sake of simplicity, the discussion has been sep-
arated into early (years 2000–2003) and later (years 2004
to present) studies. Comparative studies began to change
around 2004 when investigators began to: apply larger
sample sizes, include more microarray platforms, examine
relationships among laboratories, employ more sophisti-
cated bioinformatics approaches, and generally ﬁnd data-
sets to be more correlated. In addition to being limited in
scope (i.e. comparing only 2–3 technologies or using
small sample sizes), the early studies focused heavily
on the comparison of cDNA microarrays to other tech-
nologies.
Table I summarizes all of the experiments that we iden-
tiﬁed that examined cross-platform performance prior to
2004. Of 13 studies, 8 produced results supporting the
reproducibility and concordance of data across different
microarray technologies. These ﬁndings should be inter-
preted with caution, as they are based on the authors’
conclusions, and the term ‘‘agree’’ is somewhat ambigu-
ously deﬁned. At a time when expectations for the pros-
pects of DNA microarrays were extremely high, these
negative ﬁndings were discouraging. For example, a
widely cited article by Tan et al. [2003] examined gene
expression of technical and biological replicates of RNA
on Codelink (Amersham oligonucleotide), Affymetrix,
and Agilent cDNA arrays. Although internal consistency
was high, Pearson correlation coefﬁcients were moderate
to poor across technologies (0.48–0.59). Similarly, a com-
prehensive investigation of 56 NCI-cell lines using 2
array technologies (Affymetrix and cDNA) showed poor
correlations between the datasets [Kuo et al., 2002].
These ﬁndings led researcher to conclude that the general
outlook for comparing across laboratories and platforms
was bleak [Hardiman, 2004]. It was hypothesized that the
discrepancies in these studies arose from intrinsic dif-
ferences in the properties of the arrays, as well as the
processing and analysis of the data. As a result, it was
suggested that data from microarray analyses be inter-
preted with caution.
Subsequent studies revisited both of the datasets
described earlier (an excellent demonstration of the utility
of making microarray data publicly-available) and were
able to reanalyze the data. Reanalysis revealed signiﬁ-
cantly improved correlations, providing insight into the
basis for discrepancies found among the technologies. Shi
et al. [2005a] examined the Tan et al. [2003] data in
more detail and found that intra-platform consistency was
generally low, suggesting that experimental protocols may
Environmental and Molecular Mutagenesis. DOI 10.1002/em
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CorrelationAmongDNA Microarray Technologies 383not have been optimized for the array platform used. Fur-
thermore, by applying more appropriate statistical tests
(examining ratios instead of absolute measurements of
gene expression) they were able to signiﬁcantly increase
the correlation coefﬁcients obtained in comparisons of the
technologies. Shi et al. [2005a] concluded that a combina-
tion of low intra-platform consistency and poor choice of
data analysis procedures were the cause for discordance
among the datasets, rather than inherent technical differ-
ences among the platforms as suggested by Tan et al.
Data produced by microarray hybridization of RNA from
NCI-60 cell lines [Kuo et al., 2002] were re-evaluated by
stringent sequence mapping [Carter et al., 2005] of
matched probes. By redeﬁning probe sets, a substantially
higher level of cross-platform consistency and correlation
was found. The authors concluded that by using probes
targeting overlapping transcript sequence regions a greater
level of concordance can be obtained compared to using
UniGene ID or other sequence-matching approaches. It
should be noted that the study by Kuo et al. was carried
out in two different laboratories using cells cultured inde-
pendently, rather than using the same RNA samples
matched for both platforms. Therefore, real biological
variability will cause differences in the two datasets pro-
duced.
These early studies were key to identifying potential
sources of discrepancies between microarray datasets,
highlighting the need to investigate this issue in more
detail. As microarray technologies, annotation, and techni-
ques for analysis continue to be reﬁned, a number of im-
portant sources of error and data misinterpretation have
been identiﬁed in these early studies and are summarized
in subsequent sections.
LATERSTUDIES: 2004TOPRESENT
In 2003, discrepancies in the literature led us to carry
out our own cross-platform evaluation [Yauk et al.,
2004]. Gene expression from three replicates of three dif-
ferent RNA sources (mouse whole lung, mouse lung cell
line, and Stratagene Universal mouse reference RNA)
were evaluated with six different technologies encompass-
ing different reporter systems (short oligonucleotides,
long oligonucleotides, and cDNAs), labeling techniques,
and hybridization protocols. We were unable to match
probes through sequences, because not all platform pro-
viders made sequence information available (probes were
matched by UniGene ID). By applying rigorous ﬁltering
and normalizations, and using an adequate sample size,
we found that the top performing platforms exhibited low
levels of technical variability which resulted in an
increased ability to detect differential expression, and that
biology, rather than technology, accounted for the major-
ity of variation in the data when normalized ratios were
examined. Subsequent studies have conﬁrmed that with
improved technologies, annotations, statistical rigor, and
experimental design, the data from different microarray
platforms are highly comparable.
Table II summarizes the studies identiﬁed that exam-
ined the correlation among microarray technologies within
the last 3 years (2004 to present). Among the 32 studies
that we identiﬁed, only three concluded that microarray
platforms do not correlate well (<10%). Careful examina-
tion of these studies reveals some potential errors that the
authors may have made in reaching these conclusions.
The remaining studies show a moderate to high level of
correlation among technologies.
Studies With PoorCorrelation
Mah et al. [2004] examined RNA expression proﬁles of
human colonoscopy samples using [
33P]dCTP labeling
and hybridization to probes generated from a human
cDNA clone set spotted on nylon ﬁlters, compared to data
generated from human Affymetrix HG-U95Av2 chips.
The authors found weak correlations using Spearman rank
order coefﬁcients on normalized signal intensities between
the two systems for sequence-matched probes. Examina-
tion of absolute expression of genes fails to account for
the major role that different probe sequences and location
will play in resulting signal intensity. The same transcript
can produce different signal intensities for different
probes; even over-lapping probe sequences targeting the
same transcript can produce different signal intensities
[Draghici et al., 2006]. More recent studies emphasize
that examination of log ratios rather than expression
intensities will greatly increase the observed correlation
coefﬁcients [Park et al., 2004]. While analyses based on
signal intensities are appropriate for case-control study
designs using a single platform, the use of signal inten-
sities is not appropriate for cross-platform comparisons.
Therefore, the measurement of ratios may have yielded
increased correlation in the Mah et al. analysis.
Severgnini et al. [2006] compared Amersham Codelink
and Affymetrix microarrays through hybridization of four
samples (Human breast cancer cell line MDA-MB-231;
two treated and two untreated samples). The authors car-
ried out a hierarchical cluster analysis on genes matched
by LocusLink IDs on normalized expression levels and
found poor correlation coefﬁcients and clustering. Again,
this negative result likely reﬂects analysis on normalized
signal intensities rather than on ratios. Investigation of
differentially expressed genes was carried out independ-
ently for both platforms (rather than on the genes in com-
mon only, ﬁltered for poor/saturated/absent genes). The
authors found 105 genes differentially expressed on Affy-
metrix, and 42 on Codelink, 9 of which were found in
common. A more appropriate analysis would have been
to examine differential expression on the ﬁltered set of
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CorrelationAmongDNA Microarray Technologies 387genes in common only. Therefore, a combination of inap-
propriate statistical analysis and small sample size may
have contributed to the negative ﬁndings in this study.
Lastly, [Gwinn et al., 2005] found minimal similarity
between Affymetrix, Amersham Codelink and NCI cDNA
platforms when they analyzed three technical replicates of
a human cell culture exposed to benzo[a]pyrene compared
to three technical replicates of a control sample. We sug-
gest a few potential reasons for low correlations found in
this study. First, probes were generally matched using
gene information provided by the manufacturer. In the lat-
ter part of the study, the authors re-examined their data
and carried out some sequence investigation but the
results were not fully presented and appear to be incon-
clusive. Other potential factors contributing to the poor
correlation observed include: (a) normalizations and anal-
yses were not carried out for all platforms combined, but
were carried out individually within a platform; (b) differ-
ential expression was investigated using a small sample
size (n ¼ 3) for a subtle toxicological effect (e.g., Affy-
metrix only found 23 genes differentially expressed); (c)
signal log ratios (SLR) were arbitrarily deﬁned as differ-
entially expressed if 60.6 (with no measure of variability
or statistic presented), while similarity to the other plat-
form was arbitrarily deﬁned as within 60.2 SLR for the
same gene on another platform; (d) it is unclear what
level of ﬁltering was applied to examine the correlation
among the genes that were in common among the plat-
forms.
Studies With Moderate toHigh Correlation
Since 2004, the vast majority (29/32) of technical
papers comparing microarray platforms have generated
results that show a moderate to high degree of correlation
among the technologies. Several of these studies have
been very comprehensive encompassing many microarray
platforms analyzed in both one and two colors, employing
different probe types spotted both in-house and commer-
cially, and using data from the same samples analyzed in
several different laboratories. By ﬁne-tuning approaches
and analyses, these studies identiﬁed methods to yield
increased correlation among laboratories and platforms.
Below, we present general ﬁndings that have resulted in
increasing our understanding of how microarray platforms
relate to each other, and we discuss a few of the more
comprehensive studies.
Several studies have demonstrated that using a
sequence-driven rather than an annotation-driven approach
to analyzing data from different platforms yields
improved correlation among technologies [Mecham et al.,
2004a; Carter et al., 2005; Kuo et al., 2006]. Annotation
of microarray platforms has improved greatly over the
past several years, but errors in annotation will continue
to affect analyses until genomes are completely validated
and curated. In addition to potentially matching incorrect
probes due to errors in annotation, sequence-driven
matching improves correlation by ensuring that probe
pairs are examining similar gene regions. The re-examina-
tion of the NCI cancer cell lines [Carter et al., 2005]
using sequence-driven probe matching, described earlier,
exempliﬁes the importance of ensuring the appropriate
comparisons of probes/genes are made in cross-platform
analyses. Similarly, Stec et al. [2005] compared platforms
using either UniGene identiﬁers or by sequence matching
using BLAST alignments. They found higher correlations
when the Affymetrix probe identiﬁers were sequence-
matched to ensure they fell within the cDNA probes.
Mecham et al. [2004a] also found signiﬁcantly improved
correlation for Affymetrix compared to cDNA platforms
using sequence matching. Sequence matching eliminates
errors introduced by mis-annotation, and potential discrep-
ancies introduced by probes aligning with multiple family
members or alternative transcripts. Probes targeting re-
gions of a gene in close proximity (e.g. within the same
exon) are more likely to have highly correlated expression
ratios [Canales et al., 2006; Kuo et al., 2006].
A number of the later studies highlight the importance
of removing unreliable data from experiments prior to
analysis, termed ﬁltering. These studies generally found
that probes for genes with strong expression signal tended
to give more highly correlated results than those with
weaker signals [Park et al., 2004; Shippy et al., 2004;
Barnes et al., 2005; Pylatuik and Fobert, 2005; Kuo et al.,
2006]. Signal within the background range is highly vari-
able and contributes to much of the noise observed in
microarray datasets [Bilban et al., 2002a; Park et al.,
2004; Shippy et al., 2004; Draghici et al., 2006; Kuo
et al., 2006]. Most commercially-available image-acquisi-
tion programs now have implemented algorithms to ﬂag
poor quality, low signal, and saturated spots. Filtering
methods applied to microarray datasets prior to analysis
increases the correlation among technologies [Pounds and
Cheng, 2005; Kuo et al., 2006].
Optimization and standardization of protocols ensures
that data produced within a technology is reproducible.
Intra-platform reproducibility is obviously required before
inter-platform relationships can be evaluated. A number
of the later studies concluded that concordance was high
among the best performing laboratories, platforms, or for
commercial compared to in-house microarrays [Jarvinen
et al., 2004; Yauk et al., 2004; Bammler et al., 2005; Iri-
zarry et al., 2005; Wang et al., 2005; Kuo et al., 2006].
These results were likely due to the optimization of proto-
cols within laboratories that routinely use a technology,
technical expertise acquired in laboratories that use the
platform routinely, and increased standardization through
use and development of commercially-available microar-
rays compared to in-house microarrays. Improvements in
methodology, the development of quality control standards
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data analysis will improve the relationship among data
produced by different microarray platforms [Bammler
et al., 2005].
Recently, a number of large-scale efforts have produced
comprehensive studies evaluating microarray performance
across technologies and laboratories. Members of the
Toxicogenomics Research Consortium [Bammler et al.,
2005] examined data produced by seven laboratories and
12 microarray platforms. Each laboratory was provided
with aliquots of two different RNA samples (one liver
RNA sample and one mixture of tissues). They found that
correlation across platforms and laboratories was gener-
ally poor. However, by implementing standardized proto-
cols for RNA labeling, hybridization, ﬁltering, processing,
data acquisition, and normalization, increased reproduci-
bility was obtained. Unsurprisingly, raw intensity values
correlated poorly. The highest levels of reproducibility
obtained were between laboratories using commercial
arrays and applying standardized protocols. This analysis
yielded median correlation coefﬁcients of 0.87–0.92. The
consortium concluded that the microarray platform has a
large effect on the variability in the data, and standardiza-
tion is required to generate data that are reproducible
across laboratories. However, the group also noted that
reproducibility among platforms was generally very high
when analyses were carried out on biological categories
identiﬁed by gene ontology analysis.
Irizarry et al. [2005] examined microarray data pro-
duced by 10 different laboratories from three different
platforms using the same RNA samples. Measurement of
relative expression (e.g. ratios), rather than absolute meas-
ures of gene expression were found to correlate well
among the best performing laboratories. The authors
emphasize the importance of experience and expertise
with a platform before a laboratory can produce accurate
and reproducible data, and that laboratory effect can be a
strong variable (>platform effect). Furthermore, the
authors stress the importance of pre-processing (normal-
ization) before making any cross-platform comparisons.
Kuo et al. [2006] examined correlation among ﬁve dif-
ferent platforms encompassing both cDNA and oligo-
nucleotide microarrays, one and two-color hybridizations,
commercial and in-house chips and including results gen-
erated in two different laboratories. They matched probes
at the gene id, gene, and exon level using UniGene,
LocusLink, RefSeq, and RefSeq exon. Data mapped
through probe sequences were more correlated than
through other identiﬁers. Log ratios showed high correla-
tion (0.63–0.92) for all platforms except academic cDNA
and Compugen. Spot quality ﬁltering had a strong positive
effect on correlation coefﬁcients. Inter-laboratory Pearson
and Spearman correlations for log2 ratios were high
within platforms (0.79 for Mergen; 0.89 for Affymetrix;
0.93 for Amersham). Quantitative RT-PCR was carried
out for 160 genes and agreed well with the microarray
platforms, although RT-PCR had a larger dynamic range.
The authors concluded that with stringent preprocessing
and sequence matching, consistency and reproducibility
among platforms and laboratories was good for highly
expressed genes and variable for genes with lower expres-
sion.
A large scale real-time PCR validation experiment was
conducted by Wang et al. [2006]. The authors used Taq-
Man
1 gene expression to evaluate the performance of
Agilent and Applied Biosystems (AB) microarrays for
1375 genes. The authors compared log2 fold-changes and
found that the dynamic range was greatest for RT-PCR,
followed by AB and then Agilent. Despite differences in
the dynamic range, moderate to strong correlations of fold
change were found for AB (R
2 ¼ 0.71–0.75) and Agilent
(0.45–0.52). The estimated range of fold changes (in log2
scale) was from  10 to 10 for TaqMan
1,  4 to 6 for
AB, and  2 to 2 for Agilent, indicating ratio compression
for microarray platforms. Ratio compression was expected
because of various technical limitations (e.g., narrower
dynamic range, signal saturation, and cross-hybridiza-
tions). In the analysis of differential expression, the
authors noted that sensitivity and speciﬁcity were highest
for genes with high and medium expression levels, com-
pared to those with low expression levels.
The MicroArray Quality Control (MAQC) project eval-
uated inter- and intra-platform reproducibility in a series
of papers [Canales et al., 2006; Guo et al., 2006; Patter-
son et al., 2006; Shi et al., 2006; Shippy et al., 2006].
The project was led by US Food and Drug Administration
scientists and involved 137 participants from 51 organiza-
tions. Shi et al. [2006] presented data evaluating ﬁve rep-
licates of two distinct, high-quality RNA samples from
four titration pools using seven microarray platforms
(each platform was evaluated at three independent tests
sites). Probe sequences were mapped to the RefSeq
human mRNA database [http://www.ncbi.nlm.nih.gov/
RefSeq/; Pruitt and Maglott, 2001; Pruitt et al., 2005] and
to the AceView database [Thierry-Mieg and Thierry-
Mieg, 2006]. The relative expression between matched
probes was examined. Rank correlations of the log ratios
were in good agreement between all sites, with a median
of 0.87 (lowest was R ¼ 0.69). Generally, differentially
expressed genes showed an overlap of at least 60%, with
many comparisons yielding 80% or more between plat-
forms, and 90% within platforms (between sites). An
average overlap of 89% was found between test sites
using the same platform and 74% across one-color micro-
array platforms. The Affymetrix, Agilent, and Illumina
platforms showed correlation values of 0.90 to TaqMan
1
assays, while GE Healthcare and NCI had an average of
0.84. The results were validated using two additional
quantitative gene expression platforms [Canales et al.,
2006] that also showed high concordance. In addition,
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tolochic acid, riddelliine, and comfrey and analyzed using
four different microarray platforms were evaluated [Guo
et al., 2006]. These data showed high concordance in
inter-laboroatory and cross-platform comparisons. The
results of the MAQC project provide strong support for
inter-platform consistency and reproducibility and support
the use of microarray platforms for the quantitative char-
acterization of gene expression.
SUMMARYOFFACTORSLEADINGTO HIGHER
CORRELATIONAMONGTECHNOLOGIES
Later studies resolved many of the issues surrounding
the lack of correlation found in earlier studies. Sources of
error in the early cross-platform microarray experiments
can be divided into problems resulting from the platform
and protocols, and those that result from the experimental
design or method of analysis.
Platform Issues
One of the most important problems that arose in early
studies was incorrect annotation of probes on the various
microarray platforms. For many cDNA platforms,
sequencing of clones from the libraries spotted revealed
that a large number were incorrect or contaminated
[Halgren et al., 2001; Taylor et al., 2001; Kothapalli
et al., 2002; Jarvinen et al., 2004; Kuo et al., 2006].
Errors in annotation were not exclusive to cDNA plat-
forms. For example, Mecham et al. [2004b] examined
mammalian Affymetrix microarrays and found that
greater than 19% of the probes on each platform did not
correspond to their appropriate mRNA reference
sequence. Dai et al. [2005] investigated Affymetrix probe
information and concluded that the original probe set deﬁ-
nitions were inaccurate, and many previous conclusions
derived from GeneChip analyses could be signiﬁcantly
ﬂawed. Harbig et al. [2005] re-annotated the Affymetrix
U133 plus 2.0 arrays using BLAST matching against
documented and postulated human transcripts. They rede-
ﬁned *37% of the probes and identiﬁed more than 5,000
probesets that detected multiple transcripts. In addition to
ensuring that probes detect the correct gene, with
improvements in annotation and subsequent probe reﬁne-
ment, fewer probes on commercial arrays will hybridize
to multiple splice variants, show cross-hybridization to
other genes in the same family and hybridize to nonspe-
ciﬁc probes. Therefore, as a result of errors in annotation,
early studies that matched genes based on the annotation
provided by the manufacturer, or by the cDNA clone set
provider, were examining a large portion of incorrectly
matched gene sets.
Errors in annotation continue to be an issue that affects
every microarray technology. However, major improve-
ments have been made as more sequence information is
curated, validated, and annotated in high-quality databases
such as Refseq [http://www.ncbi.nlm.nih.gov/RefSeq/]. In
addition, in early studies probe sequence was not avail-
able and users had to trust manufacturer gene identiﬁca-
tion. Today, a large portion of microarray platform pro-
viders make all probe sequence information available; in
addition, MIAME guidelines require submission of probe
sequences for each spot on a microarray [http://www.
mged.org/Workgroups/MIAME/miame.html]. Cross-check-
ing probe sequence annotation is an important ﬁrst step for
validation of expression changes for any gene.
Other platform issues that relate to potential discrepan-
cies in cross-platform comparisons result from sub-opti-
mal printing, labeling, hybridizing, and washing methods
in early studies [Kuo et al., 2006]. In general, several of
the early studies suffered from lack of technical expertise
with microarrays and more speciﬁcally, with one of the
platforms in their comparison. Poor quality data will be
generated when inexperienced technicians carry out the
hybridization and/or sub-optimal protocols are used. The
realization and control of the effect of environmental
inﬂuences, such as ozone [Fare et al., 2003] on the ﬂuo-
rescent chemicals used, have also resulted in improved
acquisition of data. Finally, the general quality of printing
of both cDNA and oligonucleotide microarrays has
improved signiﬁcantly over the past 5 years.
In summary, methodological and platform improve-
ments have been made over the past several years that
have resulted in a decrease in the observed technical vari-
ability and resulted in superior performance. The result
has been a general increase in the measured correlation
among DNA microarray technologies.
ExperimentalDesign and AnalysisIssues
Many of the studies described in Table I suffer from
ﬂaws in experimental design. In some studies, data were
generated in different laboratories at different times using
different samples [Kuo et al., 2002]. To directly evaluate
the correlation among technologies, the exact same RNA
sample should be used across all experiments [Kawasaki,
2006]. Biological variability and tissue heterogeneity will
signiﬁcantly contribute to variance between the datasets. In
addition, many of the early studies did not apply a large
enough sample size, including both technical and biological
replicates, to arrive at the conclusions drawn. Lastly, to
investigate differential expression, samples that are sufﬁ-
ciently distinct should be examined [Kuo et al., 2006].
An important pre-processing step involves ﬁltering
microarray image data for poor quality, saturated, and
low-signal spots. Poor quality spots and saturated signal
do not accurately represent the expression of a gene. As
discussed earlier, signals near background and reaching
saturation do not provide accurate or reliable measures of
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tinely applied to data in early microarray studies and
would have greatly improved the quality of these datasets.
Appropriate statistical tools, including normalization,
clustering, and identiﬁcation of differentially expressed
genes need to be applied in any microarray experiment.
Microarray normalizations and statistical analyses have
changed over time and current methods are superior to
those applied in the early studies. In addition, microarrays
should be normalized both within and between the tech-
nologies, incorporating a normalization approach across
all of the data in the experiment [Kuo et al., 2006]. A
major ﬁnding of the MAQC consortium was that the cor-
rect tools need to be applied to identify differentially
expressed genes [Guo et al., 2006]. Surprisingly, the
authors found that traditional parametric analyses and
other microarray-tailored analyses may not derive compa-
rable gene lists from alternative technologies. The authors
suggest that gene lists generated by fold-change ranking
were more reproducible than those using other methods.
More work needs to be done to determine the most accu-
rate and reproducible methods for deriving lists of differ-
entially expressed genes from different technologies.
Early studies examining overall expression level of
genes ignored the inﬂuence of probe position and sequence
on the derived signal intensity [Draghici et al., 2006].
Improved correlations were generated when relative ratios
were compared rather than absolute measures of gene
expression in the later studies. Therefore, the measurement
of ratios (to a control or reference sample) rather than sig-
nal intensities is now generally applied in cross-platform
analyses. In addition, microarrays do not provide quantita-
tive measures, and are therefore not very precise or accu-
rate. As a result, absolute magnitude of a change should
not be compared across platforms. Rather, emphasis should
be placed on the direction of change [Kawasaki, 2006].
All of the above factors contributed to the discrepancies
observed in the ﬁrst studies examining the correlation of
expression proﬁles across DNA microarray technologies.
Subsequent changes in methods yielded improved correla-
tion metrics, as described in the remaining sections.
CONCLUSIONS
In general, microarray platforms and associated tech-
nologies and tools have improved greatly over the past
decade. As potential sources of error and reasons for dis-
crepancies between technologies are uncovered, the rela-
tionship among gene expression data produced using the
different platforms is becoming more clear. Some key
points include: (a) probe sequence will affect measured
intensity; (b) relative ratios are more comparable than
absolute measures; (c) annotation problems still compli-
cate analysis and genes should be evaluated at the
sequence level; (d) stringent ﬁltering leads to more repro-
ducible and comparable measurement of gene expression;
(e) normalization and method of data analysis will affect
the derived gene expression proﬁles; (f) validation using
an alternative method is required. The laboratory and plat-
form effect remains a major issue and comparisons need
to be drawn carefully. Ensuring the appropriate ex-
perimental design before making comparisons between
datasets is critical to acquiring meaningful correlations.
Several of the above points (in particular (d), (e), and (f))
are good microarray practice in general, and should apply
to any experiments employing this technology.
The development of standardized protocols for every-
thing from RNA labeling to data handling will also
improve the measured correlation between platforms and
laboratories. Increased automation will lead to lower tech-
nical variability and result in higher correlation among
technologies [Yauk et al., 2005]. The development of
internal and external controls will facilitate evaluation of
data quality [van Bakel and Holstege, 2004; Yauk et al.,
2006]. Implementation of standards and references will lead
to a better understanding of the relationship among the gene
expression measures from different technologies [Andersen
and Foy, 2005; Kawasaki, 2006]. Decreasing intra-platform
variability is an important ﬁrst step towards ensuring that
microarrays produce robust and reproducible data.
In conclusion, the vast majority of papers published
over the past several years support a high degree of corre-
lation among microarray technologies. Evaluation of gene
expression using alternative approaches (e.g. quantitative
real-time PCR) also supports the conclusion that microar-
rays provide reliable and reproducible measures of tran-
script levels and proﬁles. When data are acquired and
handled correctly measures of gene expression are highly
correlated. This review provides a framework identifying
several key features of general good microarray practice,
as well as identifying critical mechanisms to ensure that
data produced by different microarray technologies are
comparable.
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